RE:Useful Data and ArticlesA six-month data read-out on 38 patients currently enrolled in a PH2b prostate cancer trial is due around the end of the 2nd quarter. Some of these patients may opt for a second dose of Topsalysin, these patients will have a final data read-out released at year end, which will complete this 12 month PH2b prostate cancer study. For more information please visit: https://sphs2017.wordpress.com